These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
619 related articles for article (PubMed ID: 10223772)
1. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists. Martínez C; Albet C; Agúndez JA; Herrero E; Carrillo JA; Márquez M; Benítez J; Ortiz JA Clin Pharmacol Ther; 1999 Apr; 65(4):369-76. PubMed ID: 10223772 [TBL] [Abstract][Full Text] [Related]
2. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail". Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577 [TBL] [Abstract][Full Text] [Related]
3. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity. Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747 [TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites. Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765 [TBL] [Abstract][Full Text] [Related]
5. In vivo effects of interleukin-10 on human cytochrome P450 activity. Gorski JC; Hall SD; Becker P; Affrime MB; Cutler DL; Haehner-Daniels B Clin Pharmacol Ther; 2000 Jan; 67(1):32-43. PubMed ID: 10668851 [TBL] [Abstract][Full Text] [Related]
6. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes. Danie WA; Syrek M; Ryłko Z; Wójcikowski J Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081 [TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation. Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247 [TBL] [Abstract][Full Text] [Related]
8. [H2 antagonists as inhibitors of cytochrome P-450 in rat liver: in vitro and in vivo effects]. Carrasco M; Gaule C; Vega P; del Villar E Rev Med Chil; 1992 May; 120(5):539-44. PubMed ID: 1364175 [TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of human liver phenacetin O-deethylation by histamine and four histamine H2-receptor antagonists. Reilly PE; Mason SR; Gillam EM Xenobiotica; 1988 Apr; 18(4):381-7. PubMed ID: 2899931 [TBL] [Abstract][Full Text] [Related]
10. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Gorski JC; Huang SM; Pinto A; Hamman MA; Hilligoss JK; Zaheer NA; Desai M; Miller M; Hall SD Clin Pharmacol Ther; 2004 Jan; 75(1):89-100. PubMed ID: 14749695 [TBL] [Abstract][Full Text] [Related]
11. Effect of CYP3A inhibition on vesnarinone metabolism in humans. Wandel C; Lang CC; Cowart DC; Girard AF; Bramer S; Flockhart DA; Wood AJ Clin Pharmacol Ther; 1998 May; 63(5):506-11. PubMed ID: 9630823 [TBL] [Abstract][Full Text] [Related]
13. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation. Jones DR; Gorski JC; Hamman MA; Mayhew BS; Rider S; Hall SD J Pharmacol Exp Ther; 1999 Sep; 290(3):1116-25. PubMed ID: 10454485 [TBL] [Abstract][Full Text] [Related]
14. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. Tracy TS; Venkataramanan R; Glover DD; Caritis SN; Am J Obstet Gynecol; 2005 Feb; 192(2):633-9. PubMed ID: 15696014 [TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of rat hepatic microsomal cytochrome P-450. I. Effect of the in vivo administration of cimetidine. Chang T; Levine M; Bandiera SM; Bellward GD J Pharmacol Exp Ther; 1992 Mar; 260(3):1441-9. PubMed ID: 1545403 [TBL] [Abstract][Full Text] [Related]
16. Multiple human cytochromes contribute to biotransformation of dextromethorphan in-vitro: role of CYP2C9, CYP2C19, CYP2D6, and CYP3A. von Moltke LL; Greenblatt DJ; Grassi JM; Granda BW; Venkatakrishnan K; Schmider J; Harmatz JS; Shader RI J Pharm Pharmacol; 1998 Sep; 50(9):997-1004. PubMed ID: 9811160 [TBL] [Abstract][Full Text] [Related]
17. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction. Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617 [TBL] [Abstract][Full Text] [Related]
18. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors. Agut J; Sánchez JC; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741 [TBL] [Abstract][Full Text] [Related]
19. Drug metabolism by rat and human hepatic microsomes in response to interaction with H2-receptor antagonists. Knodell RG; Holtzman JL; Crankshaw DL; Steele NM; Stanley LN Gastroenterology; 1982 Jan; 82(1):84-8. PubMed ID: 6118314 [TBL] [Abstract][Full Text] [Related]
20. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists. Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]